Global Apoptosis Assay Kit Market Share 2024, Forecast To 2033
8 Mar, 2024
Apoptosis assay kit market surged from $5.68 billion in 2023 to $6.26 billion in 2024, with a 10.3% CAGR. Rising disease prevalence and research activities drive growth, projected at $9.41 billion in 2028, with emphasis on high-throughput screening.
Global Apoptosis Assay Kit Market Key Driver
The apoptosis assay kit market is experiencing growth due to the increasing incidence of infectious and chronic diseases. These assays aid in studying disease mechanisms. By 2050, the number of individuals aged 50 and older with chronic illnesses is projected to rise by 99.5%, indicating a significant market opportunity for apoptosis assay kits.
Get A Free Sample Of The Global Apoptosis Assay Kit Market ReportGlobal Apoptosis Assay Kit Market Segments
The apoptosis assay kit market covered in this report is segmented –
1) Product:Kits, Reagents, Instruments, Other Products
2) Assay Type:Caspase Assay, DNA Fragmentation Assay, Cell Permeability Assay, Mitochondrial Assay
3) Detection Technique:Flow Cytometry, Cell Imaging And Analysis System, Spectrophotometry, Other Detection Techniques
4) Application:Drug Discovery And Development, Clinical Research, Stem Cell Research, Basic Research
5) End-Use:Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Academic And Research Institutes
By Geography: The countries covered in the apoptosis assay kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the apoptosis assay kit market in 2023. The regions covered in the apoptosis assay kit market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Apoptosis Assay Kit Industry Players
Thermo Fisher Scientific Inc.; Danaher Corporation; Merck Group; Becton Dickinson and Company; Agilent Technologies Inc.; Lonza Group Ltd.; Sartorius AG; Bio-Rad Laboratories Inc.; Bio-Techne Corporation; Promega Corporation; GenScript Biotech Corporation; Abcam plc; BioLegend Inc.; Enzo Life Sciences AG; Cayman Chemical Company; BioVision Inc.; Cell Signaling Technology Inc.; Santa Cruz Biotechnology Inc.; GeneTex Inc.; Creative Bioarray; GE Healthcare Bio Sciences AB; Active Motif Inc.; Novus Biologicals LLC; BPS Bioscience Inc.; RayBiotech Life Inc.; Geno Technology Inc.; Biotium Inc.; GeneCopoeia Inc.; Trevigen Inc.; AAT Bioquest Inc.
Get The Full Global Apoptosis Assay Kit Market Report
Apoptosis Assay Kit Market Overview
An apoptosis assay kit refers to kits that allow for the detection of active caspases in cells using a cell-permeable, non-cytotoxic reagent. An apoptosis assay kit is used to detect and measure apoptosis, a programmed cell death process, in biological samples.